Vivo Bio Tech Ltd — Important, 30-05-2026: Company Update

Vivo Bio Tech's board has approved its audited financial results for the fourth quarter and year ended March 31, 2026. For the full year, the company reported consolidated revenue of Rs. 53.33 Cr, with a net loss after tax of Rs. 1.71 Cr. The board also approved the re-appointment of Mr. Kalyan Ram Mangipudi as Whole-time Director and material related party transactions, both pending shareholder approval. Additionally, a consultant will be appointed for a proposed Scheme of Arrangement/Amalgamation. Auditors highlighted outstanding statutory dues totaling Rs. 4.19 Cr.